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Absence of nephritogenic GBM antigen(s) in some patients with heredi-
tary nephritis. The finding of a characteristic ultrastructural lesion in the
glomerular basement membranes (GBM) of patients with hereditary
nephritis prompted us to study and characterize the GBM alteration in
patients with this condition. Both human anti-GBM sera from six
patients with Goodpasture's syndrome and heterologous rabbit antihu-
man GBM sera were used as biological tools to evaluate the antigenic
composition of GBM in kidneys from six patients representing five
families with hereditary nephritis and sensorineural deafness. All six
patients with hereditary nephritis demonstrated the characteristic GBM
ultrastructural alteration described with this condition. The human anti-
GBM sera, employed in an indirect immunofluorescence technique,
localized on 20 control kidneys (normal and diseased) but failed to
localize on GBM's of the six patients with hereditary nephritis. In
contrast, the heterologous rabbit antihuman GBM antibody localized on
all six kidneys from patients with hereditary nephritis as well as on
control kidneys. A seventh patient with apparent hereditary nephritis
and deafness received an allograft after developing renal failure. The
patient subsequently developed circulating anti-GBM antibodies which
localized in the allograft and reacted with the 20 control kidneys but not
with his own kidney or with the kidneys of the other six patients with
hereditary nephritis. The anti-GBM activity, demonstrated by indirect
immunofluorescence and radioimmunoassay, could be absorbed from
the human sera with a sonicated GBM preparation of normal kidney but
not with an equivalent weight of GBM sonicate from an hereditary
nephritis kidney. Absorption of the heterologous rabbit anti-GBM sera
with normal kidney GBM sonicate abolished fixation on all control
kidneys and on kidneys from patients with hereditary nephritis. Howev-
er, absorption of the heterologous anti-GBM sera with GBM sonicate
from a patient with hereditary nephritis abolished localization of the
antisera on kidneys from patients with hereditary nephritis while
localization on control kidneys was retained. Our study indicates that
one group of patients with hereditary nephritis lacks an antigen(s) in the
GBM which is present in normal kidneys. However, some antigen(s) in
the GBM of patients with hereditary nephritis are shared with normal
kidneys. The absent GBM antigen(s) in hereditary nephritis is related to
the nephritogenic antigen most commonly observed in Goodpasture's
syndrome.
Absence d'antigene GBM nephritogene dans des families de malades
ayant une néphrite héréditaire. L'existence de lesions ultrastructurales
caracteristiques dans Ia membrane basale glomerulaire (GBM) de
certains malades ayant une nephrite héréditaire nous a conduits a
étudier et a caractériser Ia modification de Ia GBM chez les malades
atteints de cette maladie. Nous avons utilisé des serums humains anti-
GBM provenant de six malades ayant un syndrome de Goodpasture, et
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des serums heterologues de lapin anti-GBM humaine comme outil
biologique permettant d'évaluer Ia composition antigenique de Ia GBM
de rein de malades correspondant a cinq familIes ayant une néphrite
hdréditaire et une surdité neuro-sensorielle. Chez ces 6 malades atteints
de nephrite héréditaire on trouvait l'altération ultrastructurale de Ia
GBM caracteristique décrite dans cette maladie. Les serums humains
anti-GBM, utilisés avec une technique d'immunofluorescence indir-
ecte, étaient fixes sur 20 reins contrôles (normaux ou malades), mais ne
se fixaient pas sur les GBM provenant des six malades ayant Ia nephrite
héréditaire. En revanche, les anticorps hétérologues de lapin anti-GBM
humaine se fixaient sur les 6 reins des malades ayant une néphrite
héréditaire, ainsi que sur les reins contrôles. Un septième patient, avec
une néphrite héréditaire probable et une surdité a été greffé aprés
apparition d'une insuffisance rénale. Chez ce patient sont ensuite
apparus des anticorps anti-GBM circulants qui se fixaient sur le
transplant, et qui réagissaient avec les 20 reins contrôles, mais non avec
son propre rein malade ni avec les reins des 6 autres malades ayant une
néphrite héréditaire. L'activité anti-GBM, mise en evidence par immu-
nofluorescence indirecte et dosage radio-immunologique, pouvait étre
absorbée des serums humains avec une preparation de GBM traitée par
les ultra-sons, provenant de reins normaux, mais non avec un poids
equivalent de GBM traitee par les ultra-sons, provenant de reins
atteints de nephrite héréditaire. L'absorption des serums heterologues
de lapins anti-GBM avec des GBM de rein normal supprimait Ia fixation
surtous les reins contrôles, ainsi que surles reins provenant de malades
ayant une nephrite héréditaire. NCanmoins, l'absorption de serums
anti-GBM heterologues avec des GBM d'un patient ayant une néphrite
héréditaire a supprimé Ia fixation des anti-serums sur des reins de
malades atteints de néphrite héréditaire alors que Ia fixation sur des
reins contrôles persistait. Notre etude montre qu'un groupe de malades
atteints de néphrite héréditaire manque d'un ou plusleurs antigenes de
GBM presents dans les reins normaux. Cependant, certains antigenes
de GBM de malades ayant une nephrite héréditaire sont communs avec
ceux de reins normaux. Le(s) antigene(s) de GBM manquant(s) dans Ia
néphrite héréditaire est relié a l'antigene néphritogene frequemment
observe dans le syndrome de Goodpasture.
In 1929, Alport described a hereditary form of nephritis
associated with deafness [11. Since then, the pathogenesis of
this condition has remained undefined. Study of the disease has
been hampered by its variable clinical and morphological pre-
sentations. Patients with hereditary nephritis have clinical
findings ranging from mild hematuria with normal renal function
to the nephrotic syndrome with progression to renal failure (2],
There is a confusing overlap between hereditary nephritis of the
type described by Alport and another inherited condition
known as benign familial hematuria [3, 4]. Some patients with
hereditary nephritis have sensorineural deafness while others
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do not [5]. Conversely, some members of affected families have
sensorineural deafness without renal manifestations. The con-
fusing nature of the clinical presentation is compounded by the
difficulty in obtaining accurate family histories because the
disease may skip generations within the affected pedigree. The
histopathological changes in the kidney are varied [6]. Lesions
are often minimal to nonexistent early in the course, while later,
when clinical disease becomes more prominent, the histological
pattern is variable. In some patients, the changes are primarily
those of glomerulonephritis with endocapillary proliferation,
sclerosis, segmental glomerular basement membrane (GBM)
thickening, and occasional crescents. In others, a tubulointer-
stitial nephritis predominates with tubular atrophy and intersti-
tial fibrosis with infiltration of the interstitium by chronic
inflammatory cells. Interstitial foam cells are frequently en-
countered in hereditary nephritis [7]. However, such cells may
be seen in several conditions which result in the nephrotic
syndrome and cannot be considered specific for hereditary
nephritis [6].
Direct immunofluorescence studies have contributed little in
facilitating diagnosis or in clarifying the pathogenesis of heredi-
tary nephritis. Spears, Whitworth, and Konigsmark detected
the third component of complement (C3) but no immunoglob-
ulin in glomeruli of diseased patients [81. Others have reported
either negative studies or only scant C3 localization which is of
undetermined significance [2]. Spear and Slusser [9] and Hing-
lais, GrUnfeld, and Bois [10] have described a characteristic
ultrastructural lesion in the GBM in some patients with this
disease. There is splitting and fraying of the lamina densa
portion of the GBM with areas of membrane rarification in
which may be found electron dense granules measuring up to
900 A in diameter. Less specific changes were also seen in
tubular basement membranes (TBM). These ultrastructural
observations, having been confirmed by others [11], seem to be
helpful in diagnosing the condition, and have resulted in the
diagnosis being suspected when a positive family history could
not be obtained [10].
In studies designed to further define the nature of the
basement membrane alterations in hereditary nephritis, we
have investigated its antigenic composition using anti-GBM and
anti-TBM sera from patients with Goodpasture's syndrome, as
well as heterologous antisera to human GBM and TBM as
biological tools [12]. Abnormalities in GBM have been noted in
patients with congenital nephrosis [13, 14]. GBM antigens
reactive with human anti-GBM antibodies have been reported
to be relatively deficient in infants [15], although newborn rats
are susceptible to the nephrotoxic effects of heterologous anti-
GBM antisera [16].
Methods
Hereditary nephritis was diagnosed in six patients using
family histories, clinical findings, and morphologic changes,
described below. Renal tissue samples from each of the patients
were obtained by percutaneous biopsy or at the time of bilateral
nephrectomy. The tissue was divided into three portions and
processed for light, immunofluorescence, and electron micros-
copy. The clinical course of a seventh patient with a presump-
tive diagnosis of hereditary nephritis who underwent renal
transplantation is described separately.
Light microscopy. Kidney tissue submitted for light micros-
copy was fixed in 10% neutral buffered formalin, embedded in
paraffin, sectioned at 2 to 3 p. and stained with hematoxylin,
eosin (H&E), periodic acid Schiff (PAS), and periodic acid-
methenamine silver-Masson trichrome (PAMM).
Immunofluorescence microscopy. Kidney tissue obtained for
immunofluorescence microscopic evaluation was snap-frozen
without fixation in a 7% gelatin matrix using either dry ice and
acetone or liquid nitrogen quenched with isopentane. Cryostat
sections were cut at 4 p.. Sections for direct immunofluores-
cence microscopy were washed in phosphate buffered saline
(PBS), fixed for 5 mm in acetone, washed again in PBS, and
incubated for 30 mm with fluorescein-labeled antibody prepara-
tions. Subsequently, the sections were washed again in PBS
and mounted under coverslips with 10% phosphate buffered
glycerin. Antibody preparations used for direct immunofluores-
cence microscopic studies included goat or rabbit antisera to
human IgG, 1gM, IgA, C3, Clq, C4, fibrinogen, and albumin
prepared in the laboratory or purchased commercially (Hyland
Laboratories, Costa Mesta, California). Monospecificity of the
antisera was tested by immunoelectrophoresis and Ouchterlony
double immunodiffusion. Specificity of the immunofluores-
cence reactions at the level of sensitivity of the technique was
checked by blocking and absorption studies [17, 18].
Electron microscopy. Kidney tissue obtained for electron
microscopy was fixed in 4% glutaraldehyde buffered in 0.1 M
sodium cacodylate, postfixed in 1% osmium tetroxide and
embedded in Epon epoxy resin. Thin sections were cut on a
Porter-Blum ultramicrotome and stained with lead citrate and
uranyl acetate. Sections were examined and photographed with
an Hitachi HS-8 electron microscope. In the case of two renal
biopsies, tissue was not originally submitted for electron micro-
scopic studies. In each of those instances, formalin-fixed,
paraffin-embedded tissue was removed from the paraffin block,
minced into a 1-mm tube, deparaflinized in xylene, and pre-
pared for electron microscopic studies as described above.
Human anti-GBM sera. The human anti-GBM sera contained
anti-GBM antibody activity determined by radioimmunoassay,
using collagenase solubilized and partially purified GBM as an
antigen [19, 20]. These six sera were also positive for anti-GBM
activity in an indirect immunofluorescence technique using
normal human kidney as a target substrate and fluorescein-
labeled antihuman IgG as secondary antisera.
GBM preparation. GBM was isolated from normal human
perfused cadaveric kidneys and from the kidney of patient no. 7
with hereditary nephritis by the method of Krakower and
Greenspon [21]. Purity of the whole glomerular preparation
prior to sonication, as well as purity of the GBM preparation
after sonication, was evaluated by optical microscopy.
Heterologous anti-GBM sera. The GBM sonicates of three
normal kidneys were pooled to produce the heterologous anti-
sera to human GBM. Thirty milligrams of GBM incorporated in
1.0 ml of Freund's complete adjuvant was divided into four
portions and injected in each footpad of 3.0 kg New Zealand
white rabbits. The animals were bled on day 10 and an early
immune antisera was harvested. In order to remove antibodies
to plasma components which normally contaminate GBM prep-
arations, the sera was absorbed with 1.0 ml of insolubilized
human plasma [22].
Absorption of human anti-GBM sera with GBM from normal
and hereditary nephritis kidneys. The human sera containing
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Table 1. Clinical and renal morphological findings in patients with hereditary nephritis
Renal im- Electron
Type Inter- muno- microscopy
Age Age when Serum Serum Sensori- of stitial fluores- basement
Patient at specimen Maximum albumin creatinine neural renal foam cence membrane
no. Sex onset obtained Hematuria proteinuria g/IOO ml mg/100 ml deafness lesion cells findings alterations
1 M 4 8 Gross 6.1 3.0 to 3.5 0.6 +Patient PGN
mild
+ — +++
2 M 1 3 Gross 0.2 4.9 0.6 +Family
HX
PGN
mild
0 — ++
3 M 5 15 Microscopic 5.5 3.4 0.7 +Patient FPGN
mild
+ 1gM C3
(see text)
+++
4 M 2 7 Microscopic 0.7 4.4 0.4 +Patient
+ Family
HX
FPGN
mild
+ — ++
5 M 8 10 Microscopic 3.2 2.6 13.5 +Patient
+Family
HX
ESK 0 — +
6 M 3 22 Gross 5.2 3.5 to 4.8 18.4 +Patient ESK + — ++
Abbreviations and symbols are PGN, proliferative glomerulonephritis; FPGN, focal proliferative glomerulonephritis; ESK, endstage kidney; 0,
absent. Symbols used in the last column are: +, present; +, segmental, few capillary loops involved; + +, moderate involvement of many
capillaries; + + +, marked involvement of most capillary loops.
Patient 5
1kIaa
7
o = Male Q Female 7 = Proband
• = Affected patient, blacked lower portion = renal involvement
24 blacked upper portion = auditory involvement
Death from renal disease, figure indicates age
Fig. 1. Pedigrees of patients I through 6 with hereditary nephritis.
anti-GBM antibodies were incubated with particulate GBM
sonicates of normal and hereditary nephritis kidneys in order to
determine whether anti-GBM activity could be absorbed from
the sera. Ten milligrams (wet-weight of GBM preparation) was
used to absorb 1 aliquot (0.067 ml) of human sera. Adsorption
was carried out for 30 mm at room temperature with gentle
agitation, after which the particulate GBM was separated by
centrifugation. The antisera, so adsorbed, was assayed in an
indirect immunofluorescence technique against normal kidney
using fluorescein-labeled goat anti-human IgG as a secondary
antisera. Varying amounts of the GBM preparation were also
used to absorb the anti-GBM sera obtained from patient 7 for
testing by radioimmunoassay.
Absorption of heterologous anti-GBM sera with GBM from
normal and hereditary nephritis kidneys. Starting with the neat
rabbit anti-GBM sera, two-fold dilutions in 0.067-mi aliquots
were absorbed with 10 mg of normal GBM preparation until
localization against normal human GBM, as assayed by indirect
immunofluorescence technique, was abolished. Loss of detect-
able localization occurred at a dilution of 1:512. The rabbit
antihuman GBM sera at a dilution of 1:5 12 was then absorbed
with 10 mg of the hereditary nephritis GBM preparation. This
absorbed sera was then tested for anti-GBM activity in an
indirect immunofluorescence assay against control kidneys and
against kidneys of the six patients with hereditary nephritis.
Case presentation
Patient 7, a white male, was originally found to have hematu-
na and proteinuria at 1 year of age. Recurrent bouts of gross
hematuria required hospitalization at roughly yearly intervals
through the preschool years. During the same period, the
patient experienced recurrent bouts of otitis media, and at age 6
he required a hearing aid for diminished hearing. At age 14
years, the patient was hospitalized with chronic renal failure
and hypertension. Review of the family history revealed a 13-
year-old sister with persistent proteinuria and recurrent gross
hematuria. Two other siblings were healthy. Detailed parental
history was not obtained. Physical examination revealed a
blood pressure of 160/105 mm Hg; laboratory values included a
hematocrit of 24%, 24-hr urinary protein of 1.6 g, BUN of 107
mg/l00 ml, and serum creatinine of 11.6 mg/l00 ml. Intravenous
pyelogram revealed kidneys of 5.5 and 6 cm with poor excretion
of contrast material. The patient was enrolled in a home dialysis
program and 1 year later underwent cadaveric kidney transplan-
tation.
Initially, the allograft functioned well with urine output of 150
ml/hr; however, fever and oliguria developed within 24 hr. The
patient was treated with three intravenous infusions of 100 mg
of methylprednisolone, in addition to azothioprine 100 mg/day,
and prednisolone, 60 mg/day. Creatinine clearance dropped
from approximately 80 mI/mm on the third day following
transplantation to 1 mllmin on day 8. On day 15, diuresis began
with the BUN declining to 17 mg/l00 ml and the creatinine
clearance stabilizing at around 100 ml/min. Five months after
transplantation the patient developed sudden onset of hematu-
Patients 1 and 2 Patient 3 Patient 4
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Fig. 2. APhotomicrographfrom the biopsy of a patient showing mild histologic alterations with focal increase in glomerular mesangial cellularity
and scattered interstitial foam cells (H&E, x325). B Illustration of a renal specimen showing advanced histologic alterations with variable
glomerular sclerosis, tubular atrophy, and hyperplasia, and interstitial fibrosis with a large focal collection offoam cells in the lower left region
(H&E, x150).
na with rapid deterioration of renal function requiring hemodi-
alysis, followed by removal of the transplanted kidney. Exami-
nation of the allograft nephrectomy revealed extremely active
crescentic proliferative glomerulonephritis. The patient re-
turned to home dialysis. Three months later, the patient under-
went elective host bilateral nephrectomy after experiencing
recurrent painless hematuria. The nephrectomy specimen ex-
hibited endstage kidney disease with marked cortical atrophy,
sclerosis of most glomeruli, and diffuse interstitial nephritis.
Results
Clinical observations (Table 1). In our study, hereditary
nephritis was defined in each case by findings of (I) nephritis,
(2) a family history of nephritis, and (3) sensorineural deafness
in the proband or in a family member. The first six patients
represented five families; patients 1 and 2 are first cousins. All
six patients were males varying in age from 1 to 8 years at the
onset of symptoms of renal disease. All patients presented with
either gross or microscopic hematuria. Proteinuria varied from
200 mg to 6.1 g/24 hr. Patients 1 to 4 had good renal function at
the time of tissue examination, while patients 5 and 6 had
developed renal failure. All patients had a family history of
renal disease. Pedigrees of the five families are illustrated in
Figure 1. Affected family members were obviously on the
maternal side of the pedigree of five patients. In patient 4, the
pattern of inheritance was less clear. Although there was a
history of nephritis in his maternal grandmother, there was a
strong paternal family history of deafness. Five of the six
patients had sensorineural hearing loss documented by audio-
gram. Patient 2, who was only 2 years and 8 months of age at
the time of evaluation, had no detectable hearing loss, although
he had a positive family history of sensorineural deafness.
Light microscopic studies. Four of the six patients had mild
renal parenchymal alterations characterized either by focal or
generalized mild increase in glomerular endocapillary cellular-
ity (Fig. 2). In biopsies from patients 1 and 3 rare glomeruli
exhibited either segmental sclerosis or parietal cell prolifera-
tion. Except for the presence of interstitial foam cells (Fig. 2) in
three of these four patients, no significant tubular or interstitial
alterations were evident. Patients 5 and 6, in contrast, had
endstage kidney disease with large numbers of completely
sclerotic glomeruli. While some glomeruli remained without
significant light microscopic alterations, many exhibited promi-
nent endocapillary proliferation, variable capillary wall thicken-
ing, segmental sclerosis, and parietal cell proliferation. Areas of
tubular atrophy containing mononuclear inflammatory infil-
trates were interspersed among areas of tubular hypertrophy
and hyperplasia (Fig. 2). Small arteries and arterioles exhibited
Membranoid strands, interspersed among rar/jed areas, in the lamina densa of the glomerular peripheral capillary walls (X 1500)
—
.J.A.'
isc?:41:d'bA ft.:'
646 McCoy et a!
Fig. 3.
Fig. 4. The lamina densa separated into membranoid strands with rar(fied areas containing discrete granules in this segment of glomerular
capillary basement membrane (X 17,500).
myoitimal cell proliferation. Large collections of interstitial tion of antihuman IgG, 1gM, IgA, C3, Clq, C4, fibrinogen, or
foam cells were present in the kidney of patient 6 (Fig. 2) but albumin was seen in glomeruli of five of the biopsy specimens.
were not seen in patient 5. In one specimen from patient 3 there was localization of
Direct immunofluorescence studies. No significant localiza- antihuman 1gM and C3 in a diffuse though irregular granular
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Fig. 5. Bowman's capsule disrupted with vacuoles variabb' delineated by electron dense "debris" in addition to the glomerular peripheral capillary
wall changes in Figs. 3 and 4 (x8400).
pattern along the periphery of glomerular capillary walls. This
patient had a previous renal biopsy performed 5 years earlier
which revealed no localization of the 1gM or C3.
Electron microscopic studies. Each of the six biopsy speci-
mens revealed GBM alterations characterized by splitting and
fragmentation of the lamina densa layer, resulting in rarified
areas (Figs. 3, 4 and 5). Within these rarified areas electron
dense granules were sometimes seen. In all specimens these
alterations were segmental; in some areas the GBM appeared
normal by electron microscopy, while in other areas there was
extreme attenuation. In addition to the GBM alterations,
changes were also seen in Bowman's capsule (Fig. 5) and in the
TBM (Fig. 6). The latter consisted of disruption of the TBM by
vacuoles lined by electron dense particles. Interstitial foam
cells were also observed by electron microscopy in two speci-
mens (patients 3 and 6; Fig. 6).
Indirect immunofluorescence studies. The sera of the six
patients with Goodpasture's syndrome were evaluated for anti-
GBM localization against 20 "control" specimens which in-
cluded normal and diseased kidneys. Normal kidneys consisted
of cadaveric kidneys obtained immediately postmortem for the
purpose of renal transplantation. Diseased kidneys represented
a variety of conditions including poststreptococcal proliferative
glomerulonephritis, idiopathic membranoprolilerative glomeru-
lonephritis (dense deposit type), focal proliferative glomerulo-
nephritis, endstage chronic glomerulonephritis, lipoid nephro-
sis, diabetic nephropathy, and recurrent hematuria with mini-
mal histologic alterations in patients with no known family
history of nephritis or deafness. Positive linear localization was
observed along the GBM of all controls (Fig. 7). In addition,
two of the sera from patients with Goodpasture's syndrome also
exhibited linear localization along Bowman's capsule and along
the isolated TBM. When each of the six human anti-GBM sera
were evaluated against each of the six kidney specimens from
patients with hereditary nephritis, no localization was observed
along GBM, along Bowman's capsule, or along isolated TBM
(Fig. 7). Intense diffuse linear localization was observed, how-
ever, along GBM and TBM of all six kidney specimens from
patients with hereditary nephritis using heterologous rabbit
antihuman GBM sera (Fig. 7).
Absorption of human anti-GBM sera with the normal kidney
GBM preparation abolished localization along GBM of control
kidneys (Table 2). Absorption of human anti-GBM sera with an
equivalent amount (10 mg) of GBM preparation from patient 6
with hereditary nephritis, however, did not abolish localization
of human anti-GBM sera on normal kidney GBM. Absorption
I vj 'a j4 I 2 
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Fig. 6. Similarchanges to those described in the membrane ofBowman's capsule in the tubular basement membrane in the upper left and along the
bottom of this illustration. A foam cell is present in the interstitium (x 3500).
of heterologous rabbit anti-GBM sera at a dilution of 1:512 with
10 mg of normal kidney GBM abolished GBM localization in
normal kidneys and in the six kidney specimens from the
patients with hereditary nephritis. When an equivalent amount
of GBM preparation from patient 6 with hereditary nephritis
was used to absorb the heterologous rabbit anti-GBM sera,
localization of the absorbed sera was not detected along GBM
of the six kidney specimens from patients with hereditary
nephritis but localization remained detectable along the GBM of
control kidneys.
The presence or absence of nephritogenic GBM antigen(s) in
the normal GBM and the GBM from patient 6 was also
determined by the ability of the GBM preparations to inhibit the
positive radioimmunoassay for anti-GBM antibodies present in
serum from patient 7. Prior incubation of increasing amounts of
the GBM preparations (wet weight) with the serum showed that
maximal amounts of hereditary nephritis GBM accommodated
by the volumes of reagents used in the radioimmunoassay had
no effect on binding of the radiolabeled antigen, while equiva-
lent amounts of normal GBM resulted in greater than 50%
inhibition (Table 3).
Immunological studies of the allo graft nephrectomy, host
nephrectomy, and pre- and post-transplant sera of patient 7.
Imniunofluorescence examination of the allograft nephrectomy
revealed striking linear localization of antihuman IgG with less
intense localization of antihuman C3 along glomerular capillary
walls. No IgA or 1gM deposits were found. Antihuman fibrino-
gen localized in glomerular epithelial crescents. Immunofluo-
rescence examination of the host bilateral nephrectomy did not
exhibit deposits of IgG, IgA, 1gM, or C3.
Three serum specimens obtained from the patient prior to
transplantation did not exhibit anti-GBM activity either by
indirect immunofluorescence or by radioimmunoassay. Howev-
er, anti-GBM and anti-TBM antibodies were detected prior to
transplant nephrectomy, increased after the transplant was
removed, and then began a slow decline after bilateral nephrec-
tomy three months later (Fig. 8). Serum obtained after bilateral
nephrectomy showed positive localization on GBM and on
focal TBM of all 20 control kidneys used in this study (Fig. 7)
but failed to localize on the patient's original kidney or on the
kidneys of the other six patients with hereditary nephritis.
Citrate buffer, pH 3.2, eluate from the allograft kidney was also
strongly positive for anti-GBM and focal anti-TBM activity in
indirect immunofluorescence assay and was positive by radio-
immunoassay. Only small amounts of anti-GBM activity were
recovered from the eluate of the native kidney, and the amount
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Fig. 7. A Linear localization of serum from a patient with Goodpasture's syndrome completely outlining the glomerular capillary bed of a control
kidney. (Indirect immunofluorescence, x285) B No localization of human anti-GBM serum present along glomerular, Bowman's capsule or
tubular basement membranes from the kidney of a patient with hereditary nephritis. (Indirect immunofluorescence, x285) C Heterologous rabbit
antihuman GBM serum localized diffusely along glomerular basement membranes, Bowman's capsule and tubular basement membranes of this
kidney specimen from a patient with hereditary nephritis. (Indirect immunofluorescence, x285) D Linear localization of serum from patient 7 is
seen along glomerular, Bowman's capsule, and tubular basement membranes of a control kidney. This serum was obtained following transplant
nephrectomy and bilateral nephrectomy. (Indirect immunofluorescence, x285)
Table 2. Absorption of the indirect immunofluorescence reaction of human and heterologous anti-GBM antibodies by GBM isolated from a
normal and a hereditary nephritis kidney
Type of antibody
Source of GBM for
absorption
Indirect immunofluorescence reaction
Hereditary nephritis
kidney target
Normal
kidney target
Human anti-GBM antibody
Heterologous anti-GBM antibody
Normal kidney
Hereditary nephritis kidney
Normal kidney
Hereditary nephritis kidney
—
—
blocked
blocked
blocked
not blocked
blocked
not blocked
Because the human anti-GBM antibody did not react with this target, absorption could not be done.
was not sufficient to show specific concentration in the kidney Bois, and Hinglais [23] recently separated patients with heredi-
over that expected from entrapped serum alone when calculat- tary nephritis into two groups, one with and one without the
ed in terms of reactant per microgram of IgG present in the characteristic GBM ultrastructural alteration. Patients with the
eluate and serum. GBM alteration had sensorineural deafness and characteristi-
cally had transmission of the disease through the maternal line.
Discussion The disease was more commonly associated with the nephrotic
The term hereditary nephritis has been used to encompass a syndrome and with progression to renal failure in this group, in
heterogeneous group of conditions, some of which pursue a contrast to the group without GBM alterations who usually
benign course while others progress to renal failure. GrUnfeld, pursued a benign course. The initial group of six patients
Jan Jul Jan Jul Jan Jul
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Inhibitora
Binding by
radioimmunoassay
%
Buffer 15
Normal GBM 10 sl 9
50i.l 7
Patient 6 GBM 10 .d 14
50sl 14
The inhibitor was incubated with the anti-GBM antibody overnight
before analysis of residual antibody binding activity to radiolabeled
collagenase solubilized human GBM [20].
included in our study are homogeneous in many respects,
demonstrating features similar to the group of Grünfeld, Bois,
and Hinglais [23] which progressed. (In patient 7 who under-
went renal transplantation, family history data was less com-
plete, and electron microscopic examination of the host kidney
was not available.) All were males. Five of the six patients had
obvious transmission through the maternal line. Five of the six
patients had associated sensorineural deafness. Patient 1 did
not have evidence of deafness; however, this patient was only 2
years old when evaluated and deafness associated with heredi-
tary nephritis frequently is not manifest until adolescence [24].
This patient did have a documented family history of sensori-
neural deafness. Four of the six patients in this study had
interstitial foam cells. All of the patients demonstrated electron
microscopic alterations of the GBM, which served to distin-
guish that subset of patients with hereditary nephritis studied by
GrUnfeld, Bois, and Hinglais [231, who more commonly had
progressive disease. The disease progressed to renal failure in
two patients (5 and 6) in the present series during the observa-
tion period. Further, patients 1 and 3 had heavy proteinuria
though the nephrotic syndrome was not documented.
The variation in GBM structure observed by electron micros-
copy in hereditary nephritis stimulated the hypothesis in our
study that there might also be a detectable variation in the
antigenic composition of the GBM. Evaluation of this possibili-
ty using human antisera specific for the nephritogenic antigen(s)
of anti-GBM antibody-induced Goodpasture's syndrome indeed
indicated that this antigen was not detectable in the six patients
studied.
It should be emphasized that in the two patients with ad-
vanced renal disease, glomeruli remained which appeared nor-
mal both in sections studied by light microscopy and in sections
studied by direct and indirect immunofluorescence. Thus, in no
case was the failure of localization of human GBM antisera the
result of total glomeruloscierosis with loss of basement mem-
brane structure upon which antisera could potentially localize.
Indeed, heterologous GBM sera localized prominently in each
of these kidneys. Further, although the GBM ultrastructural
alteration was segmental, with many capillary walls in glomeru-
lar tufts appearing normal, the failure of antisera localization
was complete, that is, diffuse and generalized along the capil-
lary walls. Likewise, there was no localization of the Goodpas-
ture's sera along Bowman's capsule or along TBM in any of the
hereditary nephritis kidneys, as was seen in the two anti-GBM
sera with additional anti-TBM reactivity when tested against
control kidneys.
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Fig. 8. Anti-GBM antibody activity in the serum of patient 7 prior to
transplantation, following transplantation transplant nephrecto,ny,
and bilateral nephrectomy. Antibody is expressed as a percentage of
the binding of radiolabeled (1*) collagenase solubilized glomerular
basement membrane (CSGBM). (Normal, less than 1% binding).
The cause of the GBM antigenic variation in this group of
patients with hereditary nephritis is unknown. The variation
could be congenital in nature or it could be acquired, possibly as
a result of GBM damage by agents not currently appreciated.
Two observations in our study are of interest in this regard.
First, the GBM antigen remained detectable in several condi-
tions which do potentially damage GBM, such as membranous
glomerulonephritis, poststreptococcal proliferative glomerulo-
nephritis, and idiopathic membranoproliferative glomerulone-
phritis. Second, there was complete absence of detectable anti-
GBM sera localization in patients with only minimal lesions and
no significant renal functional impairment. One of these pa-
tients (2) was only 3 years of age when the renal tissue was
examined.
The nephritogenic GBM antigen(s) probably represents only
one of at least several recognizable GBM antigens which
comprise human GBM [25]. In order to determine whether any
of the normal antigenic components of GBM were detectable in
hereditary nephritis kidneys, the six renal specimens were each
evaluated with heterologous rabbit antisera to normal human
GBM. Previous studies have indicated that antisera of this type
will form multiple precipitin bands in agar diffusion against at
least seven solubilized GBM antigens. Positive linear GBM
localization was seen in each of the six kidneys using the
heterologous GBM sera, indicating that some antigenic compo-
nent of normal kidney GBM was present in each of these
specimens. Absorption of the human and the heterologous anti-
GBM reactivity (indirect immunofluorescence and radio-
immunoassay) with normal GBM and GBM from hereditary
nephritis kidneys served to further demonstrate the absence of
at least one normal antigen in the hereditary nephritis GBM.
Not all patients with conditions thought to represent heredi-
tary nephritis have kidney tissues which fail to localize the
human anti-GBM sera. We have studied kidneys from two
patients with strong family histories of renal disease, both with
family histories of sensorineural deafness, which did localize
Table 3. Absorption of the radioimmunoassay-detected anti-GBM
antibody activity from patient 7's serum using normal and hereditary
nephritis (patient 6) GBM
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the anti-GBM sera. Electron microscopic examination of the
renal biopsy in each of these patients revealed the characteristic
GBM alteration seen in the other six patients reported in this
study. Interestingly, both of these patients, who demonstrated
only hematuria without significant proteinuria or renal function-
al impairment, were females, in contrast to the six males whose
kidneys did not localize the antisera.
In an ongoing study of renal biopsies from patients in the
families of hereditary nephritis described by O'Neill, Atkin, and
Bloomer [261, antigens reactive with a similar panel of antihu-
man GBM antibodies have been found except in one individual
with advanced renal injury (Wilson, unpublished observations).
In another recently reported study, only four of nine patients
with hereditary nephritis reacted with human anti-GBM sera
[27]. Seven other patients with hereditary nephritis have been
reported to lack antigen detectable with human anti-GBM
antibody, with the suggestion of the usefulness of this technique
in diagnosis [28]. It should be evident that patients with
hereditary nephritis lacking nephritogenic GBM antigens proba-
bly represent only a subset of patients with familial nephritis,
and the "diagnostic value" of detection of GBM antigens must
be viewed in this context. Unusual "GBM" antigens detectable
with heterologous anti-GBM antibodies have been reported in
the urine samples of some patients with Alport syndrome [29].
It will be interesting to see if there is a relationship between this
urinary material and the absent nephritogenic GBM antigen
described in this report.
Our study indicates that subsets of patients with hereditary
nephritis lack an antigen in the GBM which is present in normal
kidneys. The absent GBM antigen(s) in hereditary nephritis is
related to the nephritogenic antigen of Goodpasture syndrome.
If these conclusions are correct, then transplantation of a
normal kidney into a patient with hereditary nephritis might
result in sensitization to the deficient GBM antigen(s) [301. The
latter was documented following transplantation of patient 7,
who had sensorineural deafness and a family history of nephri-
tis. This patient developed circulating anti-GBM antibodies
which reacted with the allograft and with all the control kidneys
used in this study but failed to react with the host kidney or with
the kidneys of the other six patients with hereditary nephritis.
The frequency with which anti-GBM and/or anti-TBM anti-
bodies develop in transplant recipients with hereditary nephntis
is unknown. Two of 10 patients with Alport syndrome without
GBM antigen characterization were noted to develop anti-GBM
antibody disease after transplantation [31]. Of interest, the
single patient noted earlier to be deficient in antigen in the
families described by O'Neill, Atkin, and Bloomer did develop
anti-GBM antibody-induced glomerulonephritis in a renal trans-
plant (Wilson, unpublished observations). Development of anti-
TBM antibodies has been observed in a patient who received a
renal allograft containing TBM antigens he lacked in his native
kidney [32]. Similarly, cross-strain transplantation in rats using
TBM antigen-positive donors and TBM antigen-negative recipi-
ents results in the induction of anti-TBM antibodies in the
recipient [331.
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